Ketoconazole treatment of type 1 autoimmune polyglandular syndrome: effects on pituitary-adrenal axis.
D000324:Adrenocorticotropic Hormone; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D002180:Candidiasis, Oral / Q000188:drug therapy / Q000209:etiology; D002648:Child; D003346:Corticotropin-Releasing Hormone; D004700:Endocrine System Diseases / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D005260:Female; D005808:Genes, Recessive; D006801:Humans; D007654:Ketoconazole / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D010912:Pituitary-Adrenal Function Tests; D010913:Pituitary-Adrenal System / Q000187:drug effects* / Q000503:physiopathology
D000324:Adrenocorticotropic Hormone; D003346:Corticotropin-Releasing Hormone; D007654:Ketoconazole